We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!

0R15 9013.7197 -1.3276% 0R1E 8010.0 -1.1718% 0M69 18869.0 49.8729% 0R2V 236.01 0.2166% 0QYR 1254.0 -1.2987% 0QYP 417.0 -0.1198% 0RUK 2646.0 -9.4456% 0RYA 1380.0 -3.3613% 0RIH 162.8 0.0% 0RIH 163.3721 0.3514% 0R1O 188.19 9950.2003% 0R1O None None% 0QFP 11080.5303 119.8518% 0M2Z 268.9204 0.3996% 0VSO 34.01 -4.4797% 0R1I None None% 0QZI 569.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 177.85 -0.9854%

Danaher Corp.

GB 0R2B

266.91GBP
1.91(0.72%)

Last update at 2024-10-23T07:21:00Z

Day Range

266.91266.91
LowHigh

52 Week Range

70.47247.99
LowHigh

Fundamentals

  • Previous Close 265.00
  • Market Cap164469.49M
  • Volume3
  • P/E Ratio0.27
  • Dividend Yield0.46%
  • EBITDA9272.00M
  • Revenue TTM29566.00M
  • Revenue Per Share TTM40.29
  • Gross Profit TTM 18949.00M
  • Diluted EPS TTM8.64

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8292.00M 7598.00M 4495.00M 3305.00M 2962.00M
Minority interest - - 11.00M 11.00M 12.30M
Net income 7103.00M 6183.00M 3510.00M 2364.00M 2651.00M
Selling general administrative - 8198.00M 6896.00M 5589.00M 5391.00M
Selling and marketing expenses - - - - -
Gross profit 18949.00M 18056.00M 13043.00M 9984.00M 9505.00M
Reconciled depreciation - - - - -
Ebit 8742.00M 8168.00M 4815.00M 3281.00M 3090.00M
Ebitda 10964.00M 10336.00M 6590.00M 4470.00M -
Depreciation and amortization 2222.00M 2168.00M 1775.00M 1189.00M -
Non operating income net other - - - - -
Operating income 8742.00M 8168.00M 4815.00M 3281.00M 3055.00M
Other operating expenses 23009.00M 21628.00M 17585.00M 14637.00M 547.00M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - 1251.00M 849.00M 873.00M 563.00M
Interest income - 227.00M 204.00M 31.00M 128.00M
Net interest income - - - - -
Extraordinary items - 86.00M - 576.00M 252.00M
Non recurring - - - - -
Other items - - - - -
Income tax expense 1083.00M 1251.00M 849.00M 873.00M 556.00M
Total revenue 31471.00M 29453.00M 22284.00M 17911.00M 17049.00M
Total operating expenses 10487.00M 10231.00M 8344.00M 6710.00M -
Cost of revenue 12522.00M 11397.00M 9241.00M 7927.00M 7544.00M
Total other income expense net -450.00000M -570.00000M -320.00000M 24.00M -
Discontinued operations - 86.00M 86.00M 576.00M 245.00M
Net income from continuing ops - - - - -
Net income applicable to common shares 7103.00M 6269.00M 3510.00M 2940.00M 2651.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 84350.00M 83184.00M 76161.00M 62082.00M 47832.50M
Intangible assets 20300.00M 22843.00M 21282.00M 9750.00M 11673.10M
Earning assets - - - - -
Other current assets 1770.00M 1589.00M 1365.00M 788.00M 786.80M
Total liab 34260.00M 38007.00M 36384.00M 31800.00M 19618.10M
Total stockholder equity 50082.00M 45167.00M 39766.00M 30271.00M 28214.40M
Deferred long term liab - - - - -
Other current liab 6093.00M 5571.00M 5353.00M 3417.00M 2209.90M
Common stock 9.00M 9.00M 9.00M 8.00M 8.20M
Capital stock - - - - -
Retained earnings 39205.00M 32827.00M 27159.00M 24166.00M 25163.00M
Other liab 5922.00M 6810.00M 7004.00M 4712.00M 5075.80M
Good will 39752.00M 41184.00M 35420.00M 22713.00M 25906.00M
Other assets 3447.00M 2658.00M 1426.00M 923.00M 5587.50M
Cash 5995.00M 2586.00M 6035.00M 19912.00M 787.80M
Cash and equivalents - - - - -
Total current liabilities 8389.00M 8140.00M 7402.00M 4932.00M 4841.50M
Current deferred revenue - - - - -
Net debt -5995.00000M -2586.00000M -6035.00000M -19912.00000M -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - 22168.00M 21193.00M 21516.70M 9688.50M
Other stockholder equity 9200.00M 9063.00M 9330.00M 4497.00M -2791.10000M
Property plant equipment 4957.00M 4831.00M 4204.00M 3066.00M 2249.60M
Total current assets 15883.00M 11648.00M 13802.00M 25596.00M 7093.80M
Long term investments - - - - -
Net tangible assets -11638.00000M -22128.00000M -20204.00000M -3792.00000M -4648.90000M
Short term investments - - - - -
Net receivables 5008.00M 4706.00M 4110.00M 3268.00M 3111.80M
Long term debt - 22168.00M 21193.00M 21503.60M 9674.20M
Inventory 3110.00M 2767.00M 2292.00M 1628.00M 1631.40M
Accounts payable 2296.00M 2569.00M 2049.00M 1515.00M 1495.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -65020.00000M -68878.00000M -60933.00000M -35563.00000M -
Deferred long term asset charges - - - - -
Non current assets total 65020.00M 68878.00M 60933.00M 35563.00M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -505.00000M -808.00000M -329.00000M -241.00000M -124.00000M
Change to liabilities -554.00000M 320.00M 745.00M -397.00000M -23.00000M
Total cashflows from investing activities -2234.00000M -12987.00000M -21239.00000M -1238.00000M -2949.00000M
Net borrowings -1688.00000M 2063.00M -1900.00000M 13350.00M -442.00000M
Total cash from financing activities -2570.00000M 1295.00M 1006.00M 16365.00M -797.00000M
Change to operating activities -2.00000M 135.00M 221.00M 446.00M 134.00M
Net income 7209.00M 6433.00M 3646.00M 3008.00M 2651.00M
Change in cash 3409.00M -3449.00000M -13877.00000M 19124.00M 158.00M
Begin period cash flow 2586.00M 6035.00M 19912.00M 788.00M -
End period cash flow 5995.00M 2586.00M 6035.00M 19912.00M 788.00M
Total cash from operating activities 8519.00M 8358.00M 6208.00M 3952.00M 4022.00M
Issuance of capital stock - - - - -
Depreciation 2222.00M 2168.00M 1775.00M 1189.00M 1178.00M
Other cashflows from investing activities 51.00M 37.00M 24.00M -43.00000M -74.00000M
Dividends paid 818.00M 742.00M 615.00M 527.00M 433.00M
Change to inventory -486.00000M -502.00000M -123.00000M -22.00000M -134.00000M
Change to account receivables -477.00000M -611.00000M -264.00000M -157.00000M -55.00000M
Sale purchase of stock - 86.00M 3550.00M 3816.30M 96.00M
Other cashflows from financing activities -787.00000M 3223.00M 7554.00M 18457.00M -18.00000M
Change to netincome 607.00M 415.00M 208.00M -115.00000M 271.00M
Capital expenditures 1152.00M 1294.00M 791.00M 636.00M 584.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -963.00000M -1113.00000M -387.00000M -179.00000M 105.00M
Stock based compensation 336.00M 218.00M 187.00M 159.00M -
Other non cash items -285.00000M 652.00M 987.00M -225.00000M -
Free cash flow 7367.00M 7064.00M 5417.00M 3316.00M -

Peer Comparison

Sector: Industry:

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
0R2B
Danaher Corp.
1.91 0.72% 266.91 0.27 - 0.06 -
0M69
OTP Bank Nyrt
6310.00 50.12% 18900.00 - - - -
0RUK
MOL Hungarian Oil & Gas PLC
-290.0 9.92% 2632.00 - - - -
0RIH
Alphabet Inc Class A
- -% 164.55 - - - -
0M2Z
Equinor ASA
1.55 0.58% 269.25 - - - -

Reports Covered

Stock Research & News

Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Danaher Corp.

2200 Pennsylvania Avenue, NW, Washington, DC, United States, 20037-1701

Key Executives

Name Title Year Born
Mr. Steven M. Rales Co-Founder & Chairman 1951
Mr. Rainer M. Blair Pres, CEO & Director 1964
Mr. Mitchell P. Rales Co-Founder & Director 1957
Mr. Matthew R. McGrew CFO & Exec. VP 1972
Ms. Angela S. Lalor Part Time Advisor 1965
Mr. Joakim Weidemanis Exec. VP 1969
Ms. Jennifer L. Honeycutt Exec. VP 1970
Mr. Christopher M. Bouda Chief Accounting Officer NA
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Sr. VP & Chief Science Officer 1964
Mr. John Bedford VP of Investor Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions